These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3967250)

  • 1. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse.
    Goldfarb S; Pugh TD; Kosciuk S; Chover J
    Cancer Res; 1985 Feb; 45(2):909-12. PubMed ID: 3967250
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse.
    Vesselinovitch SD; Mihailovich N
    Cancer Res; 1983 Sep; 43(9):4253-9. PubMed ID: 6871863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal denaturation studies on rat liver chromatin during diethylnitrosamine-induced hepatocarcinogenesis.
    Letnansky K; Vardapetjan HR
    Cell Mol Biol; 1984; 30(2):117-24. PubMed ID: 6713456
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine.
    Moore MR; Drinkwater NR; Miller EC; Miller JA; Pitot HC
    Cancer Res; 1981 May; 41(5):1585-93. PubMed ID: 7214332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in aldehyde dehydrogenase activity during diethylnitrosamine- or 2-acetylaminofluorene-initiated rat hepatocarcinogenesis.
    Wischusen SM; Evces S; Lindahl R
    Cancer Res; 1983 Apr; 43(4):1710-5. PubMed ID: 6831415
    [No Abstract]   [Full Text] [Related]  

  • 6. Promotive effects of deoxycholic acid on hepatocarcinogenesis initiated by diethylnitrosamine in male rats.
    Cameron R; Imaida K; Ito N
    Gan; 1981 Aug; 72(4):635-6. PubMed ID: 6118313
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative systemic analysis of experimental models of chemical hepatic carcinogenesis in the rat].
    Lans M; de Gerlache J; Préat V; Taper H; Roberfroid M
    C R Seances Soc Biol Fil; 1984; 178(4):397-407. PubMed ID: 6151868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice.
    Hara A; Yoshimi N; Yamada Y; Matsunaga K; Kawabata K; Sugie S; Mori H
    Br J Cancer; 2000 Jan; 82(2):467-71. PubMed ID: 10646906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.
    Iwai S; Murai T; Makino S; Min W; Morimura K; Mori S; Hagihara A; Seki S; Fukushima S
    Cancer Lett; 2007 Feb; 246(1-2):115-21. PubMed ID: 16569478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between time of partial hepatectomy after a single treatment with diethylnitrosamine and induction of adenosinetriphosphatase-deficient islands in rat liver.
    Ishikawa T; Takayama S; Kitagawa T
    Cancer Res; 1980 Nov; 40(11):4261-4. PubMed ID: 6451284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
    Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
    Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infant mouse as a sensitive bioassay system for carcinogenicity of N-nitroso compounds.
    Vesselinovitch SD
    IARC Sci Publ; 1980; (31):645-55. PubMed ID: 7228287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrilobular distribution of diethylnitrosamine-induced hepatocellular foci in the mouse.
    Koen H; Pugh TD; Goldfarb S
    Lab Invest; 1983 Jul; 49(1):78-81. PubMed ID: 6865333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of liver colony formation and hepatocellular carcinoma incidence in rats receiving intravenous injections of isogeneic liver cells isolated during hepatocarcinogenesis.
    Laishes BA; Rolfe PB
    Cancer Res; 1980 Nov; 40(11):4133-43. PubMed ID: 6110475
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ornithine decarboxylase activity in malignant tumors].
    Siatkin SP; Berezov TT
    Vopr Med Khim; 1980; 26(1):121-4. PubMed ID: 7368616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of alpha-fetoprotein-positive cells in hepatocellular foci and microcarcinomas induced by single injections of diethylnitrosamine in infant mice.
    Koen H; Pugh TD; Nychka D; Goldfarb S
    Cancer Res; 1983 Feb; 43(2):702-8. PubMed ID: 6184154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo.
    Kang JS; Wanibuchi H; Morimura K; Gonzalez FJ; Fukushima S
    Cancer Res; 2007 Dec; 67(23):11141-6. PubMed ID: 18056438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the hepatocarcinogenic activity of diethylnitrosamine (DENA) by ethanol in rats.
    Habs M; Schmähl D
    Hepatogastroenterology; 1981 Oct; 28(5):242-4. PubMed ID: 7345007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of spleen on cell cycle and expression of proliferating cell nuclear antigen of the liver during diethylnitrosamine-induced rat hepatocarcinogenesis].
    Wang G; Chen X; Qiu F; Tao D
    Zhonghua Wai Ke Za Zhi; 2002 Aug; 40(8):613-5. PubMed ID: 12417078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice.
    Takagi H; Sharp R; Takayama H; Anver MR; Ward JM; Merlino G
    Cancer Res; 1993 Sep; 53(18):4329-36. PubMed ID: 8364928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.